Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $205,229 - $277,517
2,404 New
2,404 $256,000
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $170,424 - $256,938
-1,455 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $46,790 - $86,968
370 Added 34.1%
1,455 $251,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $245,014 - $399,833
1,085 New
1,085 $276,000
Q1 2021

May 13, 2021

SELL
$109.18 - $185.98 $258,319 - $440,028
-2,366 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$65.74 - $169.86 $155,540 - $401,888
2,366 New
2,366 $247,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.